Concourse Financial Group Securities, Inc. Precigen, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$0.67 - $1.12 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$0.91 - $1.88 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.27 - $1.75 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.21 - $1.75 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.89 - $1.41 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.08 - $1.85 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.08 - $1.85 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.96 - $1.4 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.27 - $2.26 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.41 - $2.79 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.15 - $2.53 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.91 - $3.98 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.53 - $5.5 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.99 - $6.55 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$6.24 - $8.22 $0 - $0
Q1 2021 May 13, 2021	BUY	$6.74 - $10.95 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.75 - $10.56 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.46 - $7.19 $0 - $0

Others Institutions Holding PGEN

# of Institutions

144

Shares Held

160M

Call Options Held

136K

Put Options Held

4.8K

Third Security, LLC

83.5M
Shares

$159 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$34.2 Million
1.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$20.8 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$19.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$15.9 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $398M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account